EconPapers    
Economics at your fingertips  
 

Storming the Beachhead: An Examination of Developed and Emerging Market Multinational Strategic Location Decisions in the U.S

Denise R. Dunlap and Roberto S. Santos
Additional contact information
Denise R. Dunlap: Manning School of Business, University of Massachusetts Lowell, One University Avenue, Lowell, MA 01854, USA
Roberto S. Santos: Manning School of Business, University of Massachusetts Lowell, One University Avenue, Lowell, MA 01854, USA

JRFM, 2021, vol. 14, issue 7, 1-15

Abstract: Entering a foreign market is challenging given the fierce competition posed by local incumbents. The literature suggests that when entering a foreign market, it is advantageous to locate where there are agglomeration benefits. Given the dynamic nature of regional development, foreign firms have multiple location options. While the literature has primarily focused on developed country multinationals’ (DMNEs) location decisions, emerging market multinationals (EMNEs) are increasingly becoming influential in high-tech industries. Due to differences in DMNE and EMNE resource endowments, they may consider alternative options when locating abroad and, thus, we examine these nuances. Using multinomial logistic regression, we investigate domestic and foreign location patterns of firms within the U.S. biopharmaceutical industry as of 2018. We constructed a unique dataset of 19,962 U.S. locations and examined the location patterns of DMNEs and EMNEs from 61 countries and territories. Given the heterogeneity of regional development in the U.S., we developed a typology that stratifies regions into four categories (developed, growth, transitioning, and nascent). Counterintuitively, we find that foreign multinationals are more likely to be attracted to less developed regions than domestic firms and have different location patterns, not only compared to domestic firms, but also with respect to each other.

Keywords: multinationals; location decisions; regional resources; DMNE; EMNE; foreign direct investment; biopharmaceutical industry; resource-based view (search for similar items in EconPapers)
JEL-codes: C E F2 F3 G (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.mdpi.com/1911-8074/14/7/325/pdf (application/pdf)
https://www.mdpi.com/1911-8074/14/7/325/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jjrfmx:v:14:y:2021:i:7:p:325-:d:594083

Access Statistics for this article

JRFM is currently edited by Ms. Chelthy Cheng

More articles in JRFM from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().

 
Page updated 2025-03-19
Handle: RePEc:gam:jjrfmx:v:14:y:2021:i:7:p:325-:d:594083